期刊文献+

雷帕霉素滴眼液对兔角膜新生血管的抑制作用 被引量:7

Inhibition of corneal neovascularization treated with rapamycin eye drops in rabbits
下载PDF
导出
摘要 背景:雷帕霉素为抗移植排斥反应的药物,近年来有实验证实雷帕霉素能有效抑制小鼠视网膜及虹膜新生血管。目的:验证新型免疫抑制剂雷帕霉素对碱烧伤诱导兔角膜新生血管的影响,并与地塞米松相比较。设计、时间及地点:随机对照动物实验,于2007-07/2008-02在重庆医科大学基础研究所免疫组织化学实验室及神经病学重点实验室完成。材料:选用健康成年新西兰家兔30只30眼,制作中度碱烧伤诱导的兔角膜新生血管模型。方法:将造模成功的30只兔30眼按随机数字表法分为5组(n=6),即10,20mg/L雷帕霉素组、2.5g/L地塞米松组、雷帕霉素溶媒组及空白对照组,空白对照组不给予任何干预措施,其余各组均于碱烧伤后第2天给予相应药物滴眼,4次/d。主要观察指标:于碱烧伤后第3,7,14天应用显微镜观察各组兔角膜新生血管的长度及面积,用免疫组织化学方法定性观察血管内皮生长因子的表达。结果:①10,20mg/L雷帕霉素组、2.5g/L地塞米松组兔角膜新生血管的长度与面积均小于雷帕霉素溶媒组及空白对照组(P<0.01),其中10,20mg/L雷帕霉素组小于2.5g/L地塞米松组(P<0.05),不同剂量的雷帕霉素组差异不明显。②角膜血管内皮生长因子在10,20mg/L雷帕霉素组及2.5g/L地塞米松组表达减弱,在雷帕霉素溶媒组与空白对照组表达增强。结论:局部滴用10,20mg/L雷帕霉素滴眼液及2.5g/L地塞米松滴眼液均可抑制碱烧伤诱导兔角膜新生血管的生长,雷帕霉素作用强于地塞米松。 BACKGROUND: Rapamycin can resist the graft rejective reaction, and recent studies have proved that rapamycin carries an inhibition effect on the retina and iris neovascularization in rats. OBJECTIVE: To evaluate the effect of immunosuppressant rapamycin on corneal neovascularization (CNV) of the rabbits induced by alkali cauterization, and compare with the effect of dexamethasone. DESIGN, TIME AND SETTING: A randomized control animal experiment was carried out in the Immunohistochemistry Laboratory and Key Laboratory of Neurology, Basic Research Institute of Chongqing Medical University (Chongqing, China) from July 2007 to February 2008. MATERIALS: Thirty healthy adult New Zealand rabbits (30 eyes) were adopted to establish the CNV model induced by moderate alkali cauterization. METHODS: CNV model was successfully induced in 30 rabbits, and then divided into five groups (n=6): 10 mg/L rapamycin treated group, 20 mg/L rapamycin treated group, 2.5 g/L dexamethasone treated group, rapamycin menstruum group and control group. Except the control group remained untreated, other four groups were treated with eye drops since the 2nd day after alkali injury, 4 times per day. MAIN OUTCOME MEASURES: The length and area of CNV in each group were examined by microscope at days 3, 7 and 14 following the injury. Immunohistochemistry was used to determine the vascular endothelial growth factor level. RESULTS: Both rapamycin and dexamethasone eye drops could inhibit the length and area of CNV in rabbits compared with rapamycin menstruum group and control group (P 〈 0.01), and the effect of 2.5 g/L dexamethasone was superior to that of 10 and 20 mg/L rapamycin (P 〈 0.05). However, there was no remarkable difference between the two concentrations of rapamycin eye drops. The expression of vascular endothelial growth factor was suppressed significantly in rapamycin and dexamethasone treated groups, nevertheless the expression was markedly increased in the rapamycin menstruum group and control group. CONCLUSION: Both local application of rapamycin and dexamethasone are effective to inhibit the CNV induced by alkaline burn, and rapamycin appears to be more effective than dexamethasone.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第18期3493-3496,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献17

  • 1Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005;97(6):512-523
  • 2Zhang Z, Ma JX, Gao G, et al. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization. Invest Ophthalmol Vis Sci 2005;46(11):4062-4071
  • 3Zhang SX, Ma JX. Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy. Prog Retin Eye Res 2007;26(1):1-37
  • 4Marimpietri D, Brignole C, Nico B, et al. Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis. Clin Cancer Res 2007;13(13):3977-3988
  • 5Land SC, Tee AR. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTor) viaan mTOR signaling motif. Biol Chem2007;282(28):20534-20543
  • 6Shi W, Gao H, Xie L, et al. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.Invest Ophthalmol Vis Sci 2006;47(8): 3339-3344
  • 7董莹,黄一飞,王丽强,陈兵.雷帕霉素抑制大鼠角膜移植免疫排斥反应的实验研究[J].中华眼科杂志,2005,41(10):930-935. 被引量:14
  • 8Dejneka NS, Kuroki AM, Fosnot J, et al. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice. Mol Vis 2004;10:964-972
  • 9Zohlnhofer D,Nuhrenberg TG,Neumann FJ,et al.Rapamycin effects transcriptional programsin smooth musclecells controlling proliferative and inflammatory properties. Mol Pharmacol 2004;65(4):880
  • 10Land SC, Tee AR. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 2007;282(28):20534-20543

二级参考文献15

  • 1崔斌,黄岚,宋耀明,李爱民,晋军,覃军,于学军,耿召华.冠心病患者循环内皮祖细胞与相关危险因素及冠状动脉病变的关系[J].中华心血管病杂志,2005,33(9):785-788. 被引量:31
  • 2崔斌,黄岚,宋耀明,耿召华,晋军.冠心病患者循环内皮祖细胞与尿酸检测及相关性[J].中国动脉硬化杂志,2006,14(1):57-60. 被引量:24
  • 3Waldock A, Cook SD. Corneal transplantation: how successful are we? Br J Ophthalmol, 2000, 84: 813-815.
  • 4Bertelmann E, Jaroszewski J, Pleyer UWE. Corneal allograft rejection: current understanding. 2. Clinical implications. Ophthalmologica, 2002, 216: 2-12.
  • 5Neubaus P, Klupp J, Langrebr JM. mTOR inhibitors: an overview. Liv Transplanta, 2001, 7:473-484.
  • 6Kahan BD, Camardo JS. Rapamycin: clinical results and future opportunities. Transplantation, 2001, 72: 1181-1193.
  • 7Holland EJ, Chan CC, Wetzig RP, et al. Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model. Cornea, 1991, 10: 374-380.
  • 8Niederkorn JY. Mechanisms of corneal graft rejection: the sixth annual thygeson lecture, presented at the ocular microbiology and immunology group meeting, October 21, 2000. Cornea, 2001, 20: 675-679.
  • 9MacDonald AS. A worldwide, phase Ⅲ, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation, 2001, 71: 271-280.
  • 10Tian L, Lu L, Yuan Z, et al. Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery. Transplantation, 2004, 77:183-189.

共引文献28

同被引文献154

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部